Table II.
Univariate and multivariate risk factors for mortality among patients with peripheral primary neuroectodermal tumors.
Univariate analysis (n=89) | Multivariate analysis (n=89) | |||
---|---|---|---|---|
Characteristics | HR (95% CI) | P-value | aHR (95% CI) | P-value |
Age, years | ||||
<20 | 1.00 | – | – | |
≥20 | 1.90 (1.08–3.32) | 0.025 | – | – |
Sex | ||||
Female | 1.00 | – | – | – |
Male | 1.39 (0.84–2.31) | 0.200 | – | – |
Tumor size, cm | ||||
≤10 | 1.00 | – | 1.00 | – |
>10 | 2.54 (1.50–4.30) | 0.001 | 3.65 (2.07–6.42) | <0.001 |
Location | ||||
Thoracopulmonary | 1.19 (0.47–2.98) | 0.714 | – | – |
Abdomen/pelvis | 1.11 (0.46–2.67) | 0.825 | – | – |
Paravertebral | 1.25 (0.38–4.11) | 0.712 | – | – |
Head and neck | 0.29 (0.06–1.45) | 0.133 | – | – |
Extremities | 1.00 | – | – | – |
Lymph nodes | ||||
No | 1.00 | – | – | – |
Yes | 1.37 (0.75–2.50) | 0.314 | – | – |
Metastasis | ||||
No | 1.00 | – | 1.00 | – |
Yes | 3.98 (2.16–7.32) | <0.001 | 4.34 (2.23–8.42) | <0.001 |
Therapy | ||||
No | 1.00 | – | 1.00 | – |
Mono-therapy | 0.38 (0.17–0.86) | 0.019 | 0.67 (0.28–1.59) | 0.358 |
Combined | 0.12 (0.05–0.29) | <0.001 | 0.16 (0.06–0.39) | <0.001 |
CI, confidence interval; HR, hazard ratio; aHR, adjusted hazard ratio.